<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Grant DJ</submitter><funding>National Institute of Environmental Health Sciences</funding><funding>National Center for Advancing Translational Sciences</funding><funding>Cancer Research UK</funding><funding>NCATS NIH HHS</funding><funding>NIEHS NIH HHS</funding><funding>Ovarian Cancer Research Fund</funding><funding>Canadian Institutes of Health Research</funding><funding>Princess Margaret Cancer Foundation</funding><funding>American Cancer Society</funding><funding>NIMHD NIH HHS</funding><funding>Cancer Institute NSW</funding><funding>National Institute for Health Research (NIHR)</funding><funding>NCI NIH HHS</funding><funding>NIH HHS</funding><pagination>2503-2513</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6536963</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(5)</volume><pubmed_abstract>An association between genetic variants in the vitamin D receptor (VDR) gene and epithelial ovarian cancer (EOC) was previously reported in women of African ancestry (AA). We sought to examine associations between genetic variants in VDR and additional genes from vitamin D biosynthesis and pathway targets (EGFR, UGT1A, UGT2A1/2, UGT2B, CYP3A4/5, CYP2R1, CYP27B1, CYP24A1, CYP11A1, and GC). Genotyping was performed using the custom-designed 533,631 SNP Illumina OncoArray with imputation to the 1,000 Genomes Phase 3 v5 reference set in 755 EOC cases, including 537 high-grade serous (HGSOC), and 1,235 controls. All subjects are of African ancestry (AA). Logistic regression was performed to estimate odds ratios (OR) and 95% confidence intervals (CI). We further evaluated statistical significanc</pubmed_abstract><journal>Cancer medicine</journal><pubmed_title>Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women.</pubmed_title><pmcid>PMC6536963</pmcid><funding_grant_id>U54 CA156735</funding_grant_id><funding_grant_id>P30 CA008748</funding_grant_id><funding_grant_id>K07 CA080668</funding_grant_id><funding_grant_id>P50 CA159981</funding_grant_id><funding_grant_id>P01 CA087969</funding_grant_id><funding_grant_id>UL1 TR001881</funding_grant_id><funding_grant_id>R03 CA113148</funding_grant_id><funding_grant_id>R01 CA160669</funding_grant_id><funding_grant_id>P30 CA071789</funding_grant_id><funding_grant_id>R01 CA122443</funding_grant_id><funding_grant_id>10119</funding_grant_id><funding_grant_id>P50 CA105009</funding_grant_id><funding_grant_id>R01 CA114343</funding_grant_id><funding_grant_id>P30 CA076292</funding_grant_id><funding_grant_id>R01 CA112523</funding_grant_id><funding_grant_id>16561</funding_grant_id><funding_grant_id>S10 OD025170</funding_grant_id><funding_grant_id>R03 CA115195</funding_grant_id><funding_grant_id>UL1 TR000124</funding_grant_id><funding_grant_id>22905</funding_grant_id><funding_grant_id>Z01 ES049033</funding_grant_id><funding_grant_id>C490/A10124</funding_grant_id><funding_grant_id>R01 CA126841</funding_grant_id><funding_grant_id>UM1 CA176726</funding_grant_id><funding_grant_id>C490/A10119</funding_grant_id><funding_grant_id>N01 CN025403</funding_grant_id><funding_grant_id>P50 CA136393</funding_grant_id><funding_grant_id>R01 CA058860</funding_grant_id><funding_grant_id>U19 CA148112</funding_grant_id><funding_grant_id>U54 MD012393</funding_grant_id><funding_grant_id>Z01 ES044005</funding_grant_id><funding_grant_id>UM1 CA186107</funding_grant_id><funding_grant_id>R01 CA142081</funding_grant_id><pubmed_authors>Taylor JA</pubmed_authors><pubmed_authors>O'Brien KM</pubmed_authors><pubmed_authors>Kennedy CJ</pubmed_authors><pubmed_authors>Setiawan VW</pubmed_authors><pubmed_authors>Cannioto R</pubmed_authors><pubmed_authors>Peters ES</pubmed_authors><pubmed_authors>Sieh W</pubmed_authors><pubmed_authors>Etter JL</pubmed_authors><pubmed_authors>Pharoah PDP</pubmed_authors><pubmed_authors>LeMarchand L</pubmed_authors><pubmed_authors>Larson MC</pubmed_authors><pubmed_authors>Salvensen HB</pubmed_authors><pubmed_authors>Moorman PG</pubmed_authors><pubmed_authors>Wang XQ</pubmed_authors><pubmed_authors>Bjorge L</pubmed_authors><pubmed_authors>Odunsi K</pubmed_authors><pubmed_authors>Gentry-Maharaj A</pubmed_authors><pubmed_authors>Kaufmann SH</pubmed_authors><pubmed_authors>Sellers TA</pubmed_authors><pubmed_authors>Cote ML</pubmed_authors><pubmed_authors>Bondy M</pubmed_authors><pubmed_authors>Kiemeney LA</pubmed_authors><pubmed_authors>Bernardini MQ</pubmed_authors><pubmed_authors>Vanderstichele A</pubmed_authors><pubmed_authors>Moffitt M</pubmed_authors><pubmed_authors>Kelemen LE</pubmed_authors><pubmed_authors>Edwards TL</pubmed_authors><pubmed_authors>Tworoger SS</pubmed_authors><pubmed_authors>Cook L</pubmed_authors><pubmed_authors>Terry PD</pubmed_authors><pubmed_authors>Eccles D</pubmed_authors><pubmed_authors>Peres LC</pubmed_authors><pubmed_authors>Ramus S</pubmed_authors><pubmed_authors>Thompson PJ</pubmed_authors><pubmed_authors>Manichaikul A</pubmed_authors><pubmed_authors>Modugno F</pubmed_authors><pubmed_authors>Ness R</pubmed_authors><pubmed_authors>Alberg AJ</pubmed_authors><pubmed_authors>Carney ME</pubmed_authors><pubmed_authors>Bruegl A</pubmed_authors><pubmed_authors>Pearce CL</pubmed_authors><pubmed_authors>Brooks-Wilson A</pubmed_authors><pubmed_authors>Berchuck A</pubmed_authors><pubmed_authors>Le ND</pubmed_authors><pubmed_authors>Karlan BY</pubmed_authors><pubmed_authors>Velez Edwards DR</pubmed_authors><pubmed_authors>Poole EM</pubmed_authors><pubmed_authors>Anton-Culver H</pubmed_authors><pubmed_authors>Terry KL</pubmed_authors><pubmed_authors>Bandera EV</pubmed_authors><pubmed_authors>Doherty JA</pubmed_authors><pubmed_authors>Monteiro AN</pubmed_authors><pubmed_authors>Levine DA</pubmed_authors><pubmed_authors>Pejovic T</pubmed_authors><pubmed_authors>Keku TO</pubmed_authors><pubmed_authors>Hoyo C</pubmed_authors><pubmed_authors>Menon U</pubmed_authors><pubmed_authors>May T</pubmed_authors><pubmed_authors>Permuth-Way JB</pubmed_authors><pubmed_authors>Funkhouser E</pubmed_authors><pubmed_authors>Massuger LFAG</pubmed_authors><pubmed_authors>Haiman CA</pubmed_authors><pubmed_authors>Van Nieuwenhuysen E</pubmed_authors><pubmed_authors>Tone AA</pubmed_authors><pubmed_authors>Moysich K</pubmed_authors><pubmed_authors>Schildkraut JM</pubmed_authors><pubmed_authors>Ziogas A</pubmed_authors><pubmed_authors>DeFazio A</pubmed_authors><pubmed_authors>Cramer DW</pubmed_authors><pubmed_authors>McGuire V</pubmed_authors><pubmed_authors>Grant DJ</pubmed_authors><pubmed_authors>Gayther S</pubmed_authors><pubmed_authors>Sandler DP</pubmed_authors><pubmed_authors>Vergote I</pubmed_authors><pubmed_authors>Huang RY</pubmed_authors><pubmed_authors>Song H</pubmed_authors><pubmed_authors>Brenton JD</pubmed_authors><pubmed_authors>Goodman MT</pubmed_authors><pubmed_authors>Wilkens LR</pubmed_authors><pubmed_authors>Campbell I</pubmed_authors><pubmed_authors>Barnholtz-Sloan J</pubmed_authors><pubmed_authors>Lambrechts D</pubmed_authors><pubmed_authors>Wentzensen N</pubmed_authors><pubmed_authors>Rothstein JH</pubmed_authors><pubmed_authors>Schwartz AG</pubmed_authors><pubmed_authors>Beeghly-Fadiel A</pubmed_authors><pubmed_authors>Wu AH</pubmed_authors><pubmed_authors>Whittemore AS</pubmed_authors><pubmed_authors>Rossing MA</pubmed_authors><pubmed_authors>Goode EL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women.</name><description>An association between genetic variants in the vitamin D receptor (VDR) gene and epithelial ovarian cancer (EOC) was previously reported in women of African ancestry (AA). We sought to examine associations between genetic variants in VDR and additional genes from vitamin D biosynthesis and pathway targets (EGFR, UGT1A, UGT2A1/2, UGT2B, CYP3A4/5, CYP2R1, CYP27B1, CYP24A1, CYP11A1, and GC). Genotyping was performed using the custom-designed 533,631 SNP Illumina OncoArray with imputation to the 1,000 Genomes Phase 3 v5 reference set in 755 EOC cases, including 537 high-grade serous (HGSOC), and 1,235 controls. All subjects are of African ancestry (AA). Logistic regression was performed to estimate odds ratios (OR) and 95% confidence intervals (CI). We further evaluated statistical significanc</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 May</publication><modification>2026-05-07T04:25:51.387Z</modification><creation>2025-05-29T20:17:43.607Z</creation></dates><accession>S-EPMC6536963</accession><cross_references><pubmed>31001917</pubmed><doi>10.1002/cam4.1996</doi></cross_references></HashMap>